Recent Articles By The Author
Several consumer financial names are benefiting from recent trends.
Replimune Group and Akebia Therapeutics provide examples of how to approach stocks in the biotech sector.
Beazer Homes USA, Olin Corp. and TravelCenters of America are showing signs of life and are worth consideration.
The early stages of the pandemic hurt sales at many biotech companies, but there are signs that revenue streams are picking back up.
One thing a Democratic sweep would do is to continue or even accelerate the exodus out of high tax cities.
Shares of Heron Therapeutics and Myovant Sciences have taken hits but both companies still show promise.
There are several reasons to believe the Russell 2000 will experience catch-up trading action in the near future.